about
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemiaAcute lymphoblastic leukaemiaTargeting Notch to overcome radiation resistanceIL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing StudyT-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments.Identification of potential predictive markers of dexamethasone resistance in childhood acute lymphoblastic leukemiaManagement of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells.Corticosteroids in brain cancer patients: benefits and pitfalls.A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALLIdentification of nuclear protein targets for six leukemogenic tyrosine kinases governed by post-translational regulation.Improved prognosis for older adolescents with acute lymphoblastic leukemia.Significant 25-hydroxyvitamin D deficiency in child and adolescent survivors of acute lymphoblastic leukemia: treatment with chemotherapy compared with allogeneic stem cell transplant.Janus kinase inhibition by ruxolitinib extends dasatinib- and dexamethasone-induced remissions in a mouse model of Ph+ ALL.Pharmacological Inhibition of O-GlcNAcase Does Not Increase Sensitivity of Glucocorticoid Receptor-Mediated Transrepression.O-GlcNAc transferase is involved in glucocorticoid receptor-mediated transrepression.Differentiation resistance through altered retinoblastoma protein function in acute lymphoblastic leukemia: in silico modeling of the deregulations in the G1/S restriction point pathway.Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancerPreclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemiaPediatric acute lymphoblastic leukemia: where are we going and how do we get there?Overcoming Steroid Resistance in T Cell Acute Lymphoblastic Leukemia.Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia.Targeting Transcription Factors in CancerMicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid MalignanciesIncidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood.Long-term remission of subcutaneous panniculitis-like T-cell lymphoma with central nervous system involvement: A case reportA 50-year journey to cure childhood acute lymphoblastic leukemiaGenetic mapping with multiple levels of phenotypic information reveals determinants of lymphocyte glucocorticoid sensitivityDexamethasone exposure and memory function in adult survivors of childhood acute lymphoblastic leukemia: A report from the SJLIFE cohort.Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01.Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysis.Steroid resistance in leukemia.Pharmacogenetics of childhood acute lymphoblastic leukemia.Glucocorticoids and Cancer.Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations.Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.The risk of infections in patients with myelodysplastic syndromes in 2016.Genetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia.In silico frameworks for systematic pre-clinical screening of potential anti-leukemia therapeutics.
P2860
Q24310753-F37B8222-9F16-4EE0-81E4-5F0D566F3F36Q24602387-46402AB1-9303-40E2-857A-30D1F0423A34Q26771701-F772FB94-5145-4351-B4AC-939925ADCC47Q28555124-A0A9D707-FFCA-40DB-AE0B-97D6D2489706Q30832305-C18DFEFA-5DD2-42E6-BF49-C072B0C0ACBBQ33714739-81C24212-D7A6-4335-BF11-BCE7762D72B7Q33762835-5E6938CD-DBA5-4857-873A-754305F660FFQ34045843-CD9B21EB-DA8C-4DCA-90DF-B8CE546541BDQ34191990-8F5C1ABA-9D97-46B1-A8C2-9E4AC5A14217Q34217173-7478BC93-7A05-44E8-B95A-4485D22104A6Q34321183-5D5BB012-0724-4515-BC02-37DDFC6985CEQ34679298-8BB752E6-A39C-41ED-ACC5-291BDC0C2EA7Q35103530-6AD5D40A-DEF6-498F-9C9D-74B39A0DD372Q35126258-E3450CD9-3175-4E79-A38A-C7EE041EEA1BQ35869321-FD5E5A08-8F43-41C7-BC06-3F3ACEE4800CQ35921622-98E9C3D0-C977-41B6-B311-000A2D157A70Q35942281-6B29B2C7-0E4B-4EB2-99FE-22FC3F094B5FQ36050483-A9990144-E136-45D9-A44B-B1903F92C158Q36084159-DBFF804F-1D4F-4098-AC46-09572382CAEBQ36163029-A0A7C9F3-ED54-4058-B949-DD70DCEC2B81Q36229432-CADDE882-31D1-4140-8E95-6D6086C65F23Q36287682-89A0AAC6-6160-418F-835A-89A14C10D0F7Q36347511-8686DCBD-9791-48B3-88E1-D3B8C4B34A59Q36602853-FBA777ED-2F0E-47C6-A96E-259F04752C34Q36895136-4A5F70A6-B981-4955-A0F2-BBE9D4792903Q36967138-DB0F1CB1-222D-4BE7-A29D-CC0D19707F51Q37002791-AC052706-1921-470B-ADB7-DCB44BBEDA20Q37166753-2595EDCB-4DBC-4A3E-8335-83FABB6A6467Q37217063-82609135-BF8C-4549-8AE7-359FFD63E71DQ37592251-3BB9D325-E49E-422F-8329-B9001AEF724EQ37741945-B0E8EE0F-665F-46F1-BFD4-12C3F69831AFQ38102644-9B23E244-4567-48ED-A8F3-371F544FB285Q38187422-553D54F0-4BFA-43E1-846B-026AAB4E223BQ38243175-AC5D1D0C-1257-4FF4-863D-E98513FE43EDQ38555471-E7CDFE70-93A6-4792-B845-EDF9DD605218Q38688039-7FB4A405-E06C-4D64-B010-DD32E2021F28Q38701181-D9064DB2-6DB8-4180-95F9-040888CD9CDFQ38813702-ADB0FF2A-475F-4CEA-BA1E-C43F1077D0F0Q38839019-883FF0A2-9E75-4252-BF07-86B62D73C5BDQ38968891-119C5917-A982-4833-853E-B05C589E7872
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Glucocorticoid use in acute lymphoblastic leukaemia
@ast
Glucocorticoid use in acute lymphoblastic leukaemia
@en
type
label
Glucocorticoid use in acute lymphoblastic leukaemia
@ast
Glucocorticoid use in acute lymphoblastic leukaemia
@en
prefLabel
Glucocorticoid use in acute lymphoblastic leukaemia
@ast
Glucocorticoid use in acute lymphoblastic leukaemia
@en
P2860
P1433
P1476
Glucocorticoid use in acute lymphoblastic leukaemia
@en
P2093
Hiroto Inaba
P2860
P304
P356
10.1016/S1470-2045(10)70114-5
P577
2010-10-12T00:00:00Z